What Is Turn Therapeutics Inc. (TTRX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Turn Therapeutics Inc.'s intrinsic value is estimated at $3.76. Trading at its current price of $9.58, the valuation engine raises significant caution: 8 of 8 models flag downside risk, projecting an average implied return of -60.7%. Model dispersion is worth noting: Sentiment SOTP targets $8.33 (-13.1%), versus Dynamic NAV at $0.12 (-98.8%). This +85.7% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About TTRX?
8 of 13 models are currently active for TTRX. All 8 active models suggest the stock trades above fair value. The Bayesian DCF estimates TTRX's intrinsic value at $1.95, implying -79.7% downside from the current price. See which stocks rank higher →
How Does TTRX Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, TTRX ranks #272 by Quality of Company score. CirclFi's QOC score of 4.6/10 evaluates 32 fundamental signals. A score of 4.6 reflects mixed fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
The Pharmaceutical Preparations sector introduces analytical considerations specific to biopharma enterprise businesses. For Turn Therapeutics Inc., metrics like R&D productivity ratio provide important context that general-purpose valuation models may underweight.
Is TTRX a Value Trap?
The Value Trap algorithm is not active for TTRX. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
8 of 13 models are active for Turn Therapeutics Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Turn Therapeutics Inc. scores 4.6 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +85.7% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every TTRX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across TTRX's 8 active models, average confidence is 15%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →